High-dose Chemotherapy as Second-line Drug Therapy for Relapsed Germ Cell Tumors — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

High-dose Chemotherapy as Second-line Drug Therapy for Relapsed Germ Cell Tumors — Stella

Home/Germ Cell Tumor/

View on ClinicalTrials.gov

Recruiting

Back to Germ Cell Tumor trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

Russia

National Medical Research Center of Oncology named after N.N.Petrov Ministry of health of Russia, Saint Petersburg, Russian Federation

Key details

Phase

Safety & dosing

Sponsor

N.N. Petrov National Medical Research Center of Oncology

Enrollment target

~25 participants

Started

March 2024

Primary completion

March 2029

Age range

18 Years and older

Sex

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

Male only

Last updated August 2025